Chronic liver allograft rejection: A national institute of diabetes and digestive and kidney diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition

American Journal of Surgical Pathology

Volumn 22, Issue 1, 1998, Pages 28-39

  Demetris, Anthony J ^a   Seaberg, Eric C ^b   Batts, Kenneth P ^c   Ferrell, Linda ^d   Lee, Randall G ^a   Markin, Rod ^e   Detre, Katherine M ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

Author keywords

Chronic liver allograft rejection

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; BILE DUCT OBSTRUCTION; CHRONIC DISEASE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; PATHOLOGIST; POSTOPERATIVE COMPLICATION; RELIABILITY; REOPERATION; REPRODUCIBILITY;

BIOPSY; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; NATIONAL INSTITUTES OF HEALTH (U.S.); OBSERVER VARIATION; PORTAL SYSTEM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 0031974326     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199801000-00004     Document Type: Article

References (33)

1. Bach N, Thung SN, Scaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992;15(4):572-7.
2. Demetris AJ, Fung JJ, Todo S, et al. Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc 1990;22(1):25-34.
3. Demetris AJ, Fung JJ, Todo S, et al. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991;23(6):3005-6.
4. Demetris AJ, Fung JJ, Todo S, et al. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy - a clinicopathologic study of 96 patient. Transplantation 1992;53(5):1056-62.
5. Demetris AJ, Jaffe R, Sheahan DG, et al. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 1986;125(1):161-72.
6. Eid A, Steffen R, Sterioff S, et al. Long-term outcome after liver transplantation. Transplant Proc 1989;21:2409-10.
7. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histological and immunological features. Hepatology 1991;13:882-91.
8. Gerber MA, Krawczynski K, Alter MJ, Sampliner RE, Margolis HS. Histopathology of community acquired chronic hepatitis C. Mod Pathol 1992;5(5):483-6.
9. Hoek BV, Wiesner R, Krom R, Ludwig J, Moore S. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment and outcome. Semin Liv Dis 1992;12:41-50.
10. Hubscher S, Neuberger JM. Chronic rejection of the liver allograft. In: Neuberger J, Adams D, eds. Immunology in Liver Transplantation. London: Edward Arnold, 1993:216-29.
11. Hubscher SG, Elias E, Buckels JAC, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993;18:173-84.
12. Hubscher SG, Neuberger JM, Buckels JAC, Elias E, McMaster P. Vanishing bile-duct syndrome after liver transplantation - is it reversible? Transplantation 1991;51:1004-110.
13. Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathologic classification of liver allograft rejection and their clinical significance. Transplant Proc 1989;21:2208-10.
14. Lautenschlager I, Hoekerstedt K, Jalanko H, et al. Persistent eytomegalovirus in liver allografts with chronic rejection. Hepatology 1997;25(1):190-4.
15. Ludwig J, Wiesner RH, Batts KP, Perkins JD, Krom RAF. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantations. Hepatology 1987;7:476-83.
16. Matsumoto Y, McCaughan G, Painter D, Bishop G. Evidence that portal tract microvascular destruction precedes bile duct loss in human allograft rejection. Transplantation 1993;56:69-75.
17. Mazariegos GV, Ramos H, Shapiro R, Zeevi A, Fung JJ, Starzl TE. Weaning of immunosuppression in long-term recipients of living transplants: a preliminary study. Transplant Proc 1995;27(1):207-9.
18. Nakhleh RE, Schwarzenberg SJ, Bloomer J, Payne W, Snover DC. The pathology of liver allografts surviving longer than one year. Hepatology 1990;11:465-70.
19. O'Connell D, Dobson AJ. General observer-agreement measures on individual subjects and groups of subjects. Biometrics 1984;40:973-83.
20. Oguma S, Belle S, Starzl TE, Fung JJ, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989;9(2):204-9.
21. Panel IW. Terminology for hepatic allograft rejection. Hepatology 1995;22:648-54.
22. Rappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995;19(2):192-206.
23. Pirsch JD, Kalayoglu M, Hafez GR, Alessandro AM, Sollinger HW, Belzer FO. Evidence that the vanishing bile-duct syndrome is vanishing. Transplantation 1990;49:1015-8.
24. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995;59(2):212-7.
25. Reyes J, Zeevi A, Ramos H, et al. Frequent achievement of a drug-free state after orthotopte liver transplantation. Transplant Proc 1993;25(6):3315-9.
26. Roberts JP, Lake JR, Herbert M, Nikolai B, Ascher NL, Ferrell LD, Reversal of chronic rejection after treatment failure with FK506 and RS61443. Transplantation 1993;56(4):1021-3.
27. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1991;15(4)567-71.
28. Shrout PB, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
29. Slapak GI, Saxena R, Portmann B, et al. Graft and systemic disease in long-term survivors of liver transplantation. Hepatology 1997;25(1):195-202.
30. Wei YL, Detre KM, Everhart JE. The NIDDK liver transplantation database. Liv Transplant Surg 1997;3:10-22.
31. White RM, Zajko AB, Demetris AJ, Bron KM, Dekker A, Starzl TE. Liver transplant rejection: angiograph findings in 35 patients. Am J Roentgen 1987;148(6):1095-8.
32. Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-meditated hepatic allograft rejection leading to ductopenia and liver failure (review). Hepatology 1991;14(4 pt 1):721-9.
33. Wight DA. Chronic liver transplant rejection: definition and diagnosis. Transplant Proc 1996;28(1):465-7.